Astex Pharmaceuticals Inc

Trending Articles

  1. Novel innovation enhances productivity and output for Polish pharma company A consultative approach to service, delivery and problem solving ensured that a Polish pharmaceutical company received the equipment and technology it needed to ramp up...
  2. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  3. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  4. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human...
  5. The new F-Gas Regulation and its impact on pharmaceutical freeze-drying Freeze-drying or lyophilization represents a pivotal process in the life sciences industry. During the past five decades, the technology involved has evolved into a complex,...

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Research & Development

Third cancer drug success for Astex drug discovery collaboration

AstraZeneca’s Truqap™ (capivasertib) in combination with Faslodex® (fulvestrant) receives US FDA marketing approval for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast cancer with one or more biomarker alterations (PIK3CA, AKT1 or PTEN)
Regulatory

Urothelial cancer treatment gets breakthrough therapy designation

Astex continues to deliver in oncology as Erdafitinib, a potential new treatment for metastatic urothelial cancer, receives US FDA breakthrough therapy designation
Research & Development

Heptares joins consortium applying cryo-electron microscopy to structure-based drug discovery

Cryo-EM can reveal the structure of complex molecular assemblies to near atomic level
Finance

Otsuka Pharmaceutical to purchase Astex

Will pay around US$866m to strengthen cancer drug and central nervous system portfolios
Subscribe now